Home Dthera Sciences

Dthera Sciences

acquired
IPO
Provider of Digital Therapeutics for Alzheimer's Disease

Basic Information

Dthera Sciences (OTC: DTHR) is a publicly traded digital therapeutics company headquartered in San Diego, dedicated to improving the quality of life (QoL) and reducing anxiety in patients with Alzheimer's disease and dementia. The company has developed non-pharmaceutical quality-of-life treatments for patients with Alzheimer's disease and dementia. Its lead product is an AI-driven digital therapeutic designed to enhance the quality of life and reduce anxiety in patients with Alzheimer's disease and dementia.
Dthera Sciences
California,United States of America
less than 15 people
January 01, 2012
Team@dthera.com